Dokter Biopsi sumsum tulang di Luar Negeri — Halaman 2

Dokter ini berspesialisasi dalam onkologi, dengan fokus pada penilaian pra-bedah, deteksi kanker, dan memberikan pendapat kedua tentang nutrisi dan gaya hidup dalam perawatan kanker. Dengan latar belakang dalam bidang kedokteran internal, dokter ini menyelesaikan magang penelitian di M. D. Anderson Cancer Center dan memiliki disertasi doktor dari Universitas Kedokteran Wina. Dokter ini pernah menjabat sebagai kepala dokter di Rumah Sakit Universitas Kedokteran Internal I di Wina dan saat ini memimpin Klinik Pribadi Josefstadt. Dokter ini telah menerbitkan lebih dari 120 makalah ilmiah dan merupakan anggota dewan dari Masyarakat Hematologi dan Onkologi Austria.<\/p>

Dr. Hasan Atilla Ozkan is a hematologist at VM Medical Park Pendik Hospital in Istanbul. He is the President of the Turkish Therapeutic Apheresis Association. Dr. Ozkan specializes in stem cell transplantation and hematological oncology. He received the Young Researcher Award at the 6th Turkish Therapeutic Apheresis Congress.

• Expert in autologous and allogeneic bone marrow transplantation.
• Treats complex blood disorders including leukemia, lymphoma, and myeloma.
• Certified in clinical phytotherapy and flow cytometry application.
• Full member of the European Bone Marrow Transplantation (EBMT) group.

Dr. Ali Ihsan Anadolulu is a surgical specialist at Central Hospital in Istanbul. He focuses on pediatric gastrointestinal surgery and anorectal malformations. Dr. Anadolulu treats complex colorectal and pelvic floor disorders in children. He uses minimally invasive techniques for pediatric surgical cases.

• Performs specialized surgeries for nephroblastoma and rhabdomyosarcoma removal.
• Treats motility disorders and anorectal malformations in pediatric patients.
• Expert in pituitary tumor surgery for children and adolescents.
• Works at Central Hospital, which features modern neonatal intensive care units.

Dokter adalah spesialis Onkologi Pediatrik dan Hemato-Onkologi yang sangat berkualifikasi di Hadassah Medical Center, diakui dalam daftar Forbes 2019-2020 sebagai dokter terbaik di Israel. Dengan lebih dari dua puluh tahun spesialisasi dalam pediatri, hemato-onkologi pediatrik, dan transplantasi sumsum tulang haploidentik, dokter ini adalah tokoh terkemuka di bidangnya.<\/p>

Dokter ini adalah lulusan Universitas Tel Aviv dan aktif terlibat dalam asosiasi profesional termasuk The Israel Society of Pediatric Hematology and Oncology, The Israeli Cancer Association, The International Association of Oncology, dan The International Society of Pediatric Oncology. Bidang minat utama termasuk retinoblastoma, pengobatan presisi, dan onkologi pediatrik.<\/p>

Dr. Boaz Liberman is the Director of the Orthopedic Oncology Unit at Sheba Medical Center. He specializes in treating bone and soft tissue sarcomas in adults and children. Dr. Liberman was recognized in the Forbes list of top doctors in Israel. He focuses on limb-sparing cancer surgery combined with functional reconstruction. Dr. Liberman completed fellowships at Mount Sinai Hospital and Princess Margaret Cancer Centre in Toronto.

• Performs complex joint reconstruction and revision hip or knee replacements.
• Uses MRgFUS to treat bone conditions with imaging-guided ultrasound.
• Treats childhood tumors like Ewing's sarcoma and rhabdomyosarcoma.
• Member of the American and European Associations of Tissue Banks.

Dr. Avichai Shimoni is the Director of Bone Marrow Transplantation at Sheba Medical Center. He treats complex blood cancers. He completed a specialized fellowship at the MD Anderson Cancer Center. Dr. Shimoni uses allogeneic and autologous transplants for high-risk patients. He is a professor and Chairman of Hematology at Tel Aviv University.

• Named among Israel’s Best Doctors by Forbes for 2025 and 2026.
• Authored over 250 scientific papers on cellular therapies and transplantation.
• Provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Abraham Avigdor is the Director of the Institute of Hematology at Sheba Medical Center. He is a global authority on lymphoma, CAR-T therapy, and complex blood cancers. Dr. Avigdor founded the Israeli Lymphoma Working Group. He helps lead a clinic ranked 7th worldwide by Newsweek in 2026.

• Authored over 130 scientific publications on hemato-oncology and cellular therapy.
• Pioneered the integration of CAR-T cell therapy for lymphoma and myeloma.
• Leads allogeneic and autologous bone marrow transplantation programs.
• Served as the Chairman of the Israeli Lymphoma Study Group.

Dr. Hila Magen is a leading Israeli hemato-oncologist at Sheba Medical Center. She heads the Multiple Myeloma and Amyloidosis Unit. Dr. Magen specializes in treating complex plasma cell disorders and high-risk myeloma. She is a principal investigator for innovative point-of-care CAR-T therapy programs. Her work brings advanced immunotherapies into routine clinical care.

• Authored over 100 scientific publications and landmark myeloma studies.
• Completed fellowships at MD Anderson and University of Arkansas for Medical Sciences.
• Performs CAR-T cell therapy and bone marrow transplantations.
• Works at Sheba Medical Center, ranked 7th worldwide in 2026 by Newsweek.

Dr. Iris Kventsel is a pediatric hemato-oncologist and bone marrow transplant specialist at Sheba Medical Center. She treats childhood sarcomas like Ewing sarcoma and osteosarcoma at the Edmond and Lily Safra Children’s Hospital. Dr. Kventsel integrates targeted therapies with cellular treatments for complex childhood cancers. She serves on the academic staff at Tel Aviv University Faculty of Medicine.

• Specializes in bone marrow transplantation and CAR T-cell therapy for pediatric patients.
• Researches genetic cancer predisposition, including Li-Fraumeni syndrome and susceptibility genes.
• Published in major journals on stem cell biology and surgical oncology (HIPEC).
• Works at Sheba Medical Center, ranked among the world’s top 10 hospitals.

Dr. Elad Jacoby is a pioneer of pediatric CAR T–cell therapy in Israel. He heads the Pediatric Cell Therapy Center at Sheba Medical Center. Dr. Jacoby specializes in treating relapsed and high-risk pediatric leukemias and lymphomas. He completed fellowships at Johns Hopkins and the U.S. National Cancer Institute.

• Medical Director of the Advanced Biotherapy Center at Sheba Medical Center.
• Authored over 240 scientific publications in pediatric hemato-oncology.
• Board-certified in both Pediatrics and Pediatric Hematology and Oncology.
• Leads the integration of CAR T–cell therapy with bone marrow transplantation.

Dokter lulus dari Sekolah Kedokteran Hacettepe pada tahun 1985 dan menjadi Spesialis Penyakit Dalam di Universitas Ege pada tahun 1990. Untuk memperdalam keahliannya, dokter tersebut mengambil spesialisasi dalam hematologi dan menyelesaikan gelar Ph.D. di Sekolah Kedokteran Mie Jepang pada tahun 1995. Pada tahun 1997, dokter tersebut telah maju menjadi Asisten Profesor dan kemudian Profesor Hematologi di Universitas Ege. Pada tahun 2003, dokter tersebut melanjutkan sebagai Profesor Hematologi di Universitas Teknik Karadeniz. Dengan lebih dari 65 artikel ilmiah, 112 makalah pertemuan, dan 34 presentasi konferensi, dokter tersebut diakui atas kontribusinya dalam hematologi dan transplantasi sumsum tulang.<\/p>

Dr. Mehmet Hilmi Dogu is a hematologist at Liv Hospital Ulus in Istanbul. He is a board member of the Society of Hematological Education and Research. Dr. Dogu authored 32 international peer-reviewed articles on hematology. He specializes in treating chronic leukemia, lymphomas, and multiple myeloma.

• Treats complex conditions like Hodgkin’s lymphoma and aplastic anemia.
• Performs specialized diagnostic procedures including HLA-typing and bone marrow biopsy.
• Member of the Turkish Society of Hematology.
• Works at JCI-accredited Liv Hospital Ulus, which serves patients from 180 countries.